期刊文献+

胰岛素泵强化治疗初诊2型糖尿病的临床疗效观察 被引量:3

Clinical observation of insulin pump therapy in newly diagnosed type 2 diabetes
原文传递
导出
摘要 目的对胰岛素泵与传统胰岛素皮下注射治疗初诊2型糖尿病的临床效果和胰岛β细胞功能改善情况进行对比。方法对67例2型糖尿病患者随机分为胰岛素泵持续皮下输注胰岛素治疗组(CSII组)35例和多次皮下输注胰岛素治疗组(MSII组)32例,观察两组的空腹血糖(FPG)、餐后2h血糖(2hPG)、每日胰岛素用量、血糖达标时间及低血糖发生情况。结果两组治疗前后血糖均明显下降(P<0.01),但两组间比较血糖差异无显著性(P>0.05),CSII组血糖达标时间明显短于MSII组(P<0.05);低血糖发生次数明显少于MSII组(P<0.05)。结论胰岛素泵持续皮下输注治疗更符合生理状态下的胰岛素分泌,能更快、更有效地降低血糖,减少低血糖的发生,同时促进了胰岛β细胞功能的恢复,对初诊2型糖尿病治疗有长期意义。 Objective To compare the clinical effect of insulin pump and conventional insulin therapy in newly diagnosed type 2 diabetes,subcutaneous injection and improvement of islet β cell function were compared.Methods Totally 67 patients with type 2 diabetes were randomly assigned to continuous subcutaneous insulin infusion pump insulin therapy(CSII group) 35 cases and multiple subcutaneous insulin infusion treatment group(MSII group) 32 cases,were observed in fasting plasma glucose(FPG),postprandial 2h plasma glucose(2hPG),daily insulin dosage,blood glucose time and the incidence of low blood sugar.Results Both before and after treatment were significantly lower blood glucose(P0.01),but blood glucose difference between the two groups was not significant(P0.05),CSII group blood glucose was significantly shorter in the MSII group(P0.05),frequency of hypoglycemia was significantly less than the MSII group(P0.05).Conclusions The continuous subcutaneous infusion insulin pump more insulin secretion under physiological conditions,faster and more effectively reduce blood sugar,reduce the incidence of low blood sugar,while promoting the recovery of islet β cell function,the treatment of newly diagnosed type 2 diabetes has long-term significance.
作者 段艳峰
出处 《医药论坛杂志》 2011年第5期109-110,115,共3页 Journal of Medical Forum
关键词 2型糖尿病 胰岛素泵 强化治疗 Type 2 diabetes mellitus Insulin pump Intensive Treatment
  • 相关文献

参考文献6

二级参考文献34

  • 1Erol Cerasi.胰岛素生成,胰岛素分泌及2型糖尿病:问题的核心在于β细胞(英文)[J].中华内分泌代谢杂志,2005,21(3):194-198. 被引量:86
  • 2吕肖锋,刘静,武晋晓,陈彬,焦秀敏,张星光.应用胰岛素泵与皮下注射胰岛素治疗糖尿病临床效果研究[J].华北国防医药,2006,18(1):26-28. 被引量:28
  • 3Li YB, Xu W, Liao ZH, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of β-cell function. Diabetes Care, 2004, 27: 2597-2602.
  • 4Osel K, Rhinesmith S, Gaillard T, et al. Impaired insulin sensitivity,insulin secretion,and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in prediabetic African Americans. Diabetes Care, 2004,27 : 1439-1446.
  • 5Gerich JE. Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes,2002,51 Suppl 1 :S117-S121.
  • 6Sundell J, Knuuti J. Insulin and myocardial blood flow. Cardiovasc Res, 2003,57:312-319.
  • 7ILKova H,Glaser B,Tunckale A,et al.Induction of long-term glycemic control in newly diagnosed type 2diabetic patients by transient intensive insulin treatment[J].Diabetes Care,1997,20:1353.
  • 8Lenhand MJ,Reeves GD.Continuous subcutaneous infusion:a comprehensive review of insulin pump[J].Arch Intern Med,2001,161:2293.
  • 9Li YB,Xu W,Liao ZH,et al.Induction of long-term glycemic control in new ly diagnosed type 2 diabetic patients is associated with improvement of β-cell function[J].Diabetes Care,2004,27:2597.
  • 10徐培红,陈宇红,王卫庆,姜蕾,李光伟,田浩明,胡仁明,郑宝忠,宁光.胰岛素粉雾剂与注射剂治疗2型糖尿病的随机对照临床研究[J].中国新药与临床杂志,2007,26(9):659-663. 被引量:6

共引文献296

同被引文献34

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部